Company profile
UK company 08139448, incorporated on 11 July 2012.
Home - CFT - Capillary Film Technology
CFT has developed FluorEx, a low-cost microfluidic fluoropolymer film that possesses unique optical transparency. The parallel array of 10 x 200 micron capillaries that allow rapid fully quantitative immunoassays to be incorporated in existing or emergent diagnostic technologies for use in the point of care clinical diagnostics market. CFT has exclusive know-how and IP. CFTs FluorEx technology is available for licensing
Company number 08139448
Updated 07 Jul 2026 09:49
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
Capillary Film Technology Ltd (CFT) is a technology and product development company for life sciences and clinical diagnostics. CFT is able to bring a disruptive manufacturing technique for the production of low-cost multiplex microfluidic material. Using exclusive know-how and IP, we are currently developing the next generation of lateral flow technology that allows rapid, fully quantitative multiplex immunoassays for field and bed-side/point-of-care use.
Main activities to date are technology development, and presentation to industrial and clinical users of diagnostic technology including at international trade fairs and through academic health science network events. In 2014, CFT secured SBRI Healthcare funding, which resulted in employment of 2 full time research scientists. IN 2015, CFT secured a further £1M SBRI Healthcare funding, which resulted in employment of 3 full time research scientists, one 0.6 FTE business development employee, and significant subcontracted research in the NIHR DEC london and product development to EG Technology Ltd. In addition, CFT has secured significant private investment (commercially confidential sum). CFT also licenses IP including IP partially derived from an EPSRC-funded project.
1 May 2020 to 31 Oct 2020
Vision Our long-term goal is to tackle the challenge of rising AMR levels that leads to reduced milk production through hard-to-treat mastitis in dairy cattle (cutting family income), and untreatable human infections. Although India is the world's largest milk producing nation, most dairy farms are not industrialised- instead thousands of small farms prov...
1 Dec 2018 to 28 Feb 2021
"POCKiT diagnostics is a UK company focused on the research and development of point-of-care diagnostic devices. Our main target is to develop a device for diagnosis of brain stroke. Stroke is the third leading cause of death and the first cause of physical disability and dementia worldwide. In stroke, the brain is damaged by restricted blood flow to the ...
